The private equity firm Welsh Carson Anderson & Stowe must get consent from the Federal Trade Commission in order to buy more anesthesiology practices under a proposed settlement.
Under the agreement, Welsh Carson must get prior approval for any acquisition of, or investment in, an anesthesia business. It will also be required to limit its representation on the board of US Anesthesia Partners—a firm it created in 2012—to a single, nonchair board seat.
The settlement resolves a potential second action against Welsh Carson over its acquisition strategy in the Texas anesthesia market, the agency said Friday. The commission approved the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.